Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy
Molecular Oncology · 2024-08 · 18 (8) · 1821-1848
DOI: 10.1002/1878-0261.13621 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 08.03.2024. Verfasst von Minmin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR‐T) cell therapy is a newly developed immunotherapy strategy and has achieved satisfactory outcomes in the treatment of hematological malignancies. However, some adverse effects related to CAR‐T cell therapy have to be resolved before it is widely used in clinics as a cancer treatment. Furthermore, the application of CAR‐T cell therapy in the treatment of solid tumors has been hampered by numerous limitations. Therefore, it is essential to explore novel strategies to improve the therapeutic effect of CAR‐T cell therapy. In this review, we summarized the recently developed strategies aimed at optimizing the generation of CAR‐T cells and improving the anti‐tumor efficiency of CAR‐T cell therapy. Furthermore, the discovery of new targets for CAR‐T cell therapy and the combined treatment strategies of CAR‐T cell therapy with chemotherapy, radiotherapy, cancer vaccines and nanomaterials are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China.
- National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China.
- Department of General Medicine, Shanxi Province Cancer Hospital, Taiyuan, China.
ORCID-Profile: Xiangpeng Dai
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jilin Province
Zitieren
APA
Wang, M., Jia, L., Dai, X., & Zhang, X. (2024). Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy. Molecular Oncology, 18(8), 1821-1848. https://doi.org/10.1002/1878-0261.13621
Vancouver
Wang M, Jia L, Dai X, Zhang X. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy. Molecular Oncology. 2024;18(8):1821-1848. doi:10.1002/1878-0261.13621
BibTeX
@article{Wang2024,
author = {Wang, Minmin and Jia, Linzi and Dai, Xiangpeng and Zhang, Xiaoling},
title = {Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy},
journal = {Molecular Oncology},
year = {2024},
volume = {18},
number = {8},
pages = {1821--1848},
doi = {10.1002/1878-0261.13621}
}
EUVIMED